The UK-based Reckitt Benckiser Group Plc. (RB.L) on Tuesday said the U.S. Environmental Protection Agency (EPA) has approved the use of its Lysol Disinfectant Spray against COVID-19.
The U.S. EPA said in a statement that the agency had approved two products, Lysol Disinfectant Spray and Lysol Disinfectant Max Cover Mist, based on laboratory testing that showed the products were effective against COVID-19.
Reckitt Benckiser reported record sales growth in the first quarter and predicted a stronger-than-expected performance in 2020 as customers stocked up on Lysol disinfectants, Mucinex cough syrup and Dettol soap. ahead of the coronavirus lockdowns.
READ ALSO: COVID-19: Dead Nigerian professor had pneumonia – Official
“Lysol is currently testing the efficacy of other disinfectant products in the brand portfolio,” Ferran Rousaud, marketing director for Lysol, said in a statement.
Lysol’s parent company has warned people against using disinfectants to treat the new coronavirus, after U.S. President Donald Trump suggested researchers try putting disinfectants into patients’ veins.
(Reuters/NAN)
Support PREMIUM TIMES' journalism of integrity and credibility
Good journalism costs a lot of money. Yet only good journalism can ensure the possibility of a good society, an accountable democracy, and a transparent government.
For continued free access to the best investigative journalism in the country we ask you to consider making a modest support to this noble endeavour.
By contributing to PREMIUM TIMES, you are helping to sustain a journalism of relevance and ensuring it remains free and available to all.
TEXT AD: To advertise here . Call Willie +2347088095401...
![A man is being tested for COVID-19 in Nigeria [PHOTO: TW: @NCDCgov]](https://i0.wp.com/media.premiumtimesng.com/wp-content/files/2020/08/EevF243X0AEt286.jpg?resize=120%2C86&ssl=1)
![A family is being tested for COVID-19 in Nigeria [PHOTO: TW: @NCDCgov]](https://i0.wp.com/media.premiumtimesng.com/wp-content/files/2020/08/EevF4PWXsAEjcyo.jpg?resize=120%2C86&ssl=1)
JOIN THE CONVERSATION